CVE-2024-2275: Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting
A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Affected Software
Event History
Frequently Asked Questions
What is the severity of CVE-2024-2275?
The vulnerability CVE-2024-2275 is classified as problematic.
Which software is affected by CVE-2024-2275?
CVE-2024-2275 affects Bdtask G-Prescription Gynaecology & OBS Consultation Software version 1.0.
What components are impacted in CVE-2024-2275?
CVE-2024-2275 impacts the OBS Patient/Gynee Prescription component.
How can CVE-2024-2275 be mitigated?
Mitigation for CVE-2024-2275 may involve updating to a newer, patched version of the affected software.
What type of vulnerabilities does CVE-2024-2275 include?
CVE-2024-2275 includes manipulation of critical arguments such as Patient Title, Full Name, and Address.